Cancer Gene Therapy Market By Therapy (Gene Induced Immunotherapy (Delivery of Cytokines Gene, Delivery of Tumor Antigen Gene), Oncolytic Virotherapy (Adenovirus, Lentivirus, Retro Virus, Adeno Associated Virus, Herpes Simplex Virus, Alpha Virus, Vaccinia Virus, Simian Virus, Others), Gene Transfer (Naked/Plasmid Vectors (Electroporation, Sonoportion, Magnetofection, Gene Gun)), Industry Analysis, COVID-19 Impact Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2028

  • Published On: Feb, 2019
  • Category: Healthcare
  • Pages: 0
The global Cancer Gene Therapy market size is estimated at 15.86 billion USD with a CAGR of 30.75% during the forecasted period from 2021-2028.

The global Cancer Gene Therapy market size is estimated at 15.86 billion USD with a CAGR of 30.75% during the forecasted period from 2021-2028. A technique wherein a patient’s gene is modified to treat or cure a disease. This therapy involves addition of genes or replacement of damaged genes to combat disease. The key factors driving the Cancer Gene Therapy is attributed to increasing occurrence of cancer and large geriatric pool. In addition, increasing awareness among people regarding gene therapy along with favorable insurance policies is projected to boost the market size. Moreover, rise in R&D activities and an increase in funding is fostering the Cancer Gene Therapy market. Furthermore, technical innovations in products are anticipated to create lucrative opportunities for the growth of this market. Besides, a changing standard of living coupled with focus on healthcare is anticipated to enhance the market during the forecast period. Likewise, surge in demand and inclination for non-invasive treatment is assessed to encourage the market growth. On the other hand, factors such as high cost associated with this therapy is expected to obstruct the market growth. Cancer takes place as a result of the production of multiple mutations in a single cell that causes it to proliferate out of control. Cancer cells can be differentiated from their usual neighbors on the basis of specific phenotypic changes, such as rapid division rate, attack of new cellular areas, high metabolic rate, and altered shape. The cancer patients who are not cured by surgeries, radiations, and chemotherapies, are treated by gene therapy. Gene therapy is the insertion of a functional gene into the cells of a patient to correct an inborn error of metabolism, in order to alter or repair an acquired genetic abnormality, and to provide a new function to a cell. Owing to high success rate throughout the preclinical and clinical trials, cancer gene therapy is gaining popularity.

Cancer Gene Therapy Market Determinants

Improvised technological advancements, increased adoption of developing genomic technologies such as next generation sequencing (NGS) and high density micro array are some of the major factors that will drive the global cancer gene therapy market in next upcoming years. Additionally, increasing number of cancer cases will increase the demand for gene therapy as an effective personalized treatment choice. However, high cost of gene therapy treatment and unwanted immune responses are the major factors restraining the growth of cancer gene therapy. On the other hand, ethical acceptance of gene therapy for cancers, untapped markets in developing economies and the technological progressions principal to higher adoption rate are expected to provide new paths for the growing of cancer gene therapy market in the future.

Cancer Gene Therapy Market Key Segments:

• By Therapy o Gene Induced Immunotherapy Delivery of Cytokines Gene Delivery of Tumor Antigen Gene o Oncolytic Virotherapy Adenovirus Lentivirus Retro Virus Adeno Associated Virus Herpes Simplex Virus Alpha Virus Vaccinia Virus Simian Virus Others o Gene Transfer Naked/Plasmid Vectors Electroporation Sonoportion Magnetofection Gene Gun • By End User Hospitals Diagnostics Centers Research Institutes • By Geography o North America U.S. Canada Mexico o Europe Germany UK France Spain Rest of Europe o Asia-Pacific Japan China Australia India Rest of Asia-Pacific o Rest of World Brazil South Africa Saudi Arabia Rest of World

Table of Content

o OncoGenex Pharmaceuticals
o SynerGene Therapeutics
o Shenzhen SiBiono GeneTech
o BioCancell
o Shanghai Sunway Biotech
o Celgene
o Merck
o Bluebird bio, Inc.
o GlaxoSmithKline
o Adaptimmune

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments